Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta-analysis with meta-regression.
Dario GiuglianoGiuseppe BellastellaMiriam LongoLorenzo ScappaticcioMaria Ida MaiorinoPaolo ChiodiniKatherine EspositoPublished in: Diabetes, obesity & metabolism (2020)
The blood glucose reduction observed in CVOTs may play some role in reducing the risk of non-fatal stroke, at least during treatment with GLP-1RAs, without affecting the other two components of MACE.